Recent research has focused on the effectiveness of quaternary ammonium compounds (QACs) in combating Methicillin-resistant Staphylococcus aureus (MRSA) infections. One study found that certain QACs were able to effectively eliminate MRSA biofilms, which are notoriously difficult to treat. The researchers utilized a combination of in vitro and in vivo experiments to demonstrate the efficacy of QACs in eradicating MRSA, suggesting their potential use in clinical settings. Another study investigated the mechanism of action of QACs against MRSA and found that they disrupt the bacterial cell membrane, leading to cell death. These findings highlight the promising role of QACs in combating MRSA infections and suggest further research into their use as antimicrobial agents.